Agency Information Collection Activities Under Emergency Review by the Office of Management and Budget, 50386 [2018-21716]
Download as PDF
<![CDATA[
50386
Federal Register / Vol. 83, No. 194 / Friday, October 5, 2018 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 28, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–21646 Filed 10–4–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities Under Emergency Review by
the Office of Management and Budget
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) has submitted the following
request (see below) for emergency OMB
review under the Paperwork Reduction
Act (44 U.S.C. Chapter 35). OMB
approval has been requested by October
25, 2018. A copy of the information
collection plans may be obtained by
calling the SAMHSA Reports Clearance
Officer on (240) 276–1243.
Title: 2019 National Survey on Drug
Use and Health.
OMB Number: 0930–0110.
Frequency: Annual.
Affected Public: Individuals or
Households.
The National Survey on Drug Use and
Health (NSDUH) is a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
The data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
federal government agencies, and other
organizations and researchers to
establish policy, direct program
activities, and better allocate resources.
While NSDUH must be updated
periodically to reflect changing
substance use and mental health issues
and to continue producing current data,
for the 2019 NSDUH only the following
minor changes are planned: (1) Adding
a brief series of questions on
medication-assistance treatment (MAT)
for opioids and alcohol; (2) two
questions about the use of kratom (a
tropical tree, native to Southeast Asia,
with leaves that have psychotropic
effects and is generally regarded as an
opioid given its known properties); and
(3) included other minor wording
changes to improve the flow of the
interview, increase respondent
comprehension or to be consistent with
text in other questions.
The series of MAT questions seeks to
identify medications prescribed by
health professionals to help reduce or
stop the use of opioids or alcohol.
Including these questions in NSDUH
will allow SAMHSA to provide the first
known national-level estimates on the
use of MAT for opioid use disorder or
alcohol use disorder. The two questions
on kratom will provide the first
national, systematic epidemiological or
survey data on its use in this country
and establish a baseline for the use of
kratom—an easily accessible,
unregulated, opioid-like drug. Not
currently illegal in the United States,
kratom is easy to order on the internet,
typically ingested as a leaf, pill or
capsule and contains chemical
compounds which interact with opioid
receptors in the brain. Some users of
kratom products reported becoming
addicted to the drug.
As with all NSDUH/NHSDA (Prior to
2002, the NSDUH was referred to as the
National Household Survey on Drug
Abuse) surveys conducted since 1999,
the sample size of the survey for 2019
will be sufficient to permit prevalence
estimates for each of the fifty states and
the District of Columbia. The total
annual burden estimate is shown below
in Table 1.
TABLE 1—ANNUALIZED ESTIMATED BURDEN FOR 2019 NSDUH
Number of
respondents
daltland on DSKBBV9HB2PROD with NOTICES
Instrument
Responses
per respondent
Total number
of responses
Hours per
response
Total
burden hours
Household Screening ...........................................................
Interview ...............................................................................
Screening Verification ..........................................................
Interview Verification ............................................................
137,231
67,507
4,116
10,126
1
1
1
1
137,231
67,507
4,116
10,126
0.083
1.000
0.067
0.067
11,390
67,507
276
678
Total ..............................................................................
137,231
........................
218,980
........................
79,851
Emergency approval is being
requested because SAMHSA has
determined that the kratom questions
will provide the first national,
systematic epidemiological or survey
data on its use in this country and
establish a baseline for the use of
kratom—an easily accessible,
unregulated, opioid-like drug. Some
users of kratom products reported
becoming addicted to the drug. Because
of these additional questions, this
Federal Register notice is a revision
from the one that was published on May
31, 2018.
Written comments and
recommendations concerning the
proposed information collection should
be sent by October 24, 2018 Elyse
VerDate Sep<11>2014
17:11 Oct 04, 2018
Jkt 247001
Greenwald, SAMHSA’s Desk Officer at
the Office of Information and Regulatory
Affairs, Office of Management and
Budget (OMB). To ensure timely receipt
of comments, and to avoid potential
delays in OMB’s receipt and processing
of mail sent through the U.S. Postal
Service, commenters are encouraged to
submit their comments to OMB via
email to: OIRA_Submission@
omb.eop.gov. Although commenters are
encouraged to send their comments via
email, commenters may also fax their
comments to: 202–395–7285.
Commenters may also mail them to:
Office of Management and Budget,
Office of Information and Regulatory
PO 00000
Frm 00056
Fmt 4703
Sfmt 9990
Affairs, New Executive Office Building,
Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2018–21716 Filed 10–4–18; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 83, Number 194 (Friday, October 5, 2018)]
[Notices]
[Page 50386]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21716]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities Under Emergency Review
by the Office of Management and Budget
The Substance Abuse and Mental Health Services Administration
(SAMHSA) has submitted the following request (see below) for emergency
OMB review under the Paperwork Reduction Act (44 U.S.C. Chapter 35).
OMB approval has been requested by October 25, 2018. A copy of the
information collection plans may be obtained by calling the SAMHSA
Reports Clearance Officer on (240) 276-1243.
Title: 2019 National Survey on Drug Use and Health.
OMB Number: 0930-0110.
Frequency: Annual.
Affected Public: Individuals or Households.
The National Survey on Drug Use and Health (NSDUH) is a survey of
the U.S. civilian, non-institutionalized population aged 12 years old
or older. The data are used to determine the prevalence of use of
tobacco products, alcohol, illicit substances, and illicit use of
prescription drugs. The results are used by SAMHSA, the Office of
National Drug Control Policy (ONDCP), federal government agencies, and
other organizations and researchers to establish policy, direct program
activities, and better allocate resources.
While NSDUH must be updated periodically to reflect changing
substance use and mental health issues and to continue producing
current data, for the 2019 NSDUH only the following minor changes are
planned: (1) Adding a brief series of questions on medication-
assistance treatment (MAT) for opioids and alcohol; (2) two questions
about the use of kratom (a tropical tree, native to Southeast Asia,
with leaves that have psychotropic effects and is generally regarded as
an opioid given its known properties); and (3) included other minor
wording changes to improve the flow of the interview, increase
respondent comprehension or to be consistent with text in other
questions.
The series of MAT questions seeks to identify medications
prescribed by health professionals to help reduce or stop the use of
opioids or alcohol. Including these questions in NSDUH will allow
SAMHSA to provide the first known national-level estimates on the use
of MAT for opioid use disorder or alcohol use disorder. The two
questions on kratom will provide the first national, systematic
epidemiological or survey data on its use in this country and establish
a baseline for the use of kratom--an easily accessible, unregulated,
opioid-like drug. Not currently illegal in the United States, kratom is
easy to order on the internet, typically ingested as a leaf, pill or
capsule and contains chemical compounds which interact with opioid
receptors in the brain. Some users of kratom products reported becoming
addicted to the drug.
As with all NSDUH/NHSDA (Prior to 2002, the NSDUH was referred to
as the National Household Survey on Drug Abuse) surveys conducted since
1999, the sample size of the survey for 2019 will be sufficient to
permit prevalence estimates for each of the fifty states and the
District of Columbia. The total annual burden estimate is shown below
in Table 1.
Table 1--Annualized Estimated Burden for 2019 NSDUH
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Household Screening............. 137,231 1 137,231 0.083 11,390
Interview....................... 67,507 1 67,507 1.000 67,507
Screening Verification.......... 4,116 1 4,116 0.067 276
Interview Verification.......... 10,126 1 10,126 0.067 678
-------------------------------------------------------------------------------
Total....................... 137,231 .............. 218,980 .............. 79,851
----------------------------------------------------------------------------------------------------------------
Emergency approval is being requested because SAMHSA has determined
that the kratom questions will provide the first national, systematic
epidemiological or survey data on its use in this country and establish
a baseline for the use of kratom--an easily accessible, unregulated,
opioid-like drug. Some users of kratom products reported becoming
addicted to the drug. Because of these additional questions, this
Federal Register notice is a revision from the one that was published
on May 31, 2018.
Written comments and recommendations concerning the proposed
information collection should be sent by October 24, 2018 Elyse
Greenwald, SAMHSA's Desk Officer at the Office of Information and
Regulatory Affairs, Office of Management and Budget (OMB). To ensure
timely receipt of comments, and to avoid potential delays in OMB's
receipt and processing of mail sent through the U.S. Postal Service,
commenters are encouraged to submit their comments to OMB via email to:
[email protected]. Although commenters are encouraged to send
their comments via email, commenters may also fax their comments to:
202-395-7285. Commenters may also mail them to: Office of Management
and Budget, Office of Information and Regulatory Affairs, New Executive
Office Building, Room 10102, Washington, DC 20503.
Summer King,
Statistician.
[FR Doc. 2018-21716 Filed 10-4-18; 8:45 am]
BILLING CODE 4162-20-P
